Clinical Chemistry Analyzers Market Worth $11,728.01 Million by 2019

DALLAS, October 23, 2014 /PRNewswire/ --

According to the new market research report The "Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals), & by End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019", published by marketsandmarkets, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global clinical chemistry analyzers market along with the estimates and forecasts of the revenue and market share analysis.

Browse 78 market tables and 127 figures spread through 200 pages on "Clinical Chemistry Analyzer Market"
http://www.marketsandmarkets.com/Market-Reports/clinical-chemistry-analyzer-market-144027310.html

Early buyers will receive 10% customization on this report. 

The global clinical chemistry analyzers market was estimated at $8,965 Million in 2014. This market is expected to grow at a CAGR of 5.52% between 2014 and 2019, to reach $11,728.01 Million in 2019.

The Clinical Chemistry Analyzers Market is segmented on the basis of products as analyzers, reagents and other products. Analyzers segment is further divided on the basis of sizes into four segments: Small Sized (400-800 Test/H), Medium Sized (800-1,200 Tests/H), Large Sized (1,200-2,000 Tests/H), Very large Sized (2,000 Tests/H). The analyzer product segment had the largest share of the clinical chemistry analyzers market in 2014, whereas the reagents product segment is expected to grow at the highest CAGR between 2014 and 2019. Reagents segment is further categorized into calibrators, controls, standards and other reagents. The reagents product segment is expected to grow at the highest CAGR between 2014 and 2019.

Further Inquiry:http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=144027310

The application segments included in this report are tests such as, basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests. The basic metabolic panel tests segment had the largest share of the Clinical Chemistry Analyzers Market in 2014, whereas the lipid profile test segment is expected to grow at the highest CAGR between 2014 and 2019.

The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW).

Rise in number of lifestyle diseases, automation of laboratories will aid the growth of this market. The market is expected to be driven by increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation.

The major players in the Clinical Chemistry Analyzers Market include Roche Diagnostics (Switzerland), Danaher Corporation (U.S.), Abbott Diagnostics (U.S.), Siemens AG (Germany), Ortho-Clinical Diagnostics(U.S.), Thermo Fisher Scientific(U.S.), Randox Laboratories Ltd.(U.K.), ElitechGroup (France), Mindray (China),and Horiba(Japan).

 Browse related reports 

Hematology Analyzers & Reagents Market by Products (3-& 5- part hematology Analyzers, Point-of-Care, & Fully Automated), Consumables (Reagents & Stains), End Users (Research Institute, Hospital, & Clinical Testing Labs) - Global Forecasts to 2019
http://www.marketsandmarkets.com/Market-Reports/hematology-analyzers-reagents-market-153222146.html

Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

 About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog http://mnmblog.org/market-research/healthcare/medical-devices